Cargando…
The tumour associated antigen CA15.3 in primary breast cancer. Evaluation of 667 cases.
CA15.3 preoperatory serum levels have been determined in 667 patients with primary untreated breast cancer and in 193 controls. The relationships between CA15.3 and several clinical and pathological parameters were evaluated. CA15.3 levels showed a highly significant direct relationship with stage,...
Autores principales: | Gion, M., Mione, R., Nascimben, O., Valsecchi, M., Gatti, C., Leon, A., Bruscagnin, G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1972400/ https://www.ncbi.nlm.nih.gov/pubmed/2039707 |
Ejemplares similares
-
Serum CA549 in primary breast cancer: comparison with CA15.3 and MCA.
por: Gion, M., et al.
Publicado: (1994) -
PS2 in breast cancer--alternative or complementary tool to steroid receptor status? Evaluation of 446 cases.
por: Gion, M., et al.
Publicado: (1993) -
Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases
por: Nicolini, Andrea, et al.
Publicado: (2006) -
Symptomatic metastasis prediction with serial measurements of CA 15.3 in primary breast cancer patients
por: Bahrami-Ahmadi, Amir, et al.
Publicado: (2012) -
Detection of secondary metastatic breast cancer by measurement of plasma CA 15.3
por: De Cock, L., et al.
Publicado: (2021)